+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Molecular Diagnostics Market Size and Forecasts 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product; Technology; Application; and End-User- Product Image
Molecular Diagnostics Market Size and Forecasts 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product; Technology; Application; and End-User- Product Image
New

Molecular Diagnostics Market Size and Forecasts 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product; Technology; Application; and End-User

  • PDF Icon

    Report

  • 132 Pages
  • August 2024
  • Region: Global
  • IHR Insights
  • ID: 5995344
10% Free customization
Description Jump to:
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
This report provides an in-depth analysis of the molecular diagnostics market from 2020 to 2030. The report covers key trends, drivers, challenges, and opportunities shaping the market. It includes a comprehensive examination of market dynamics, competitive landscape, and regional variations, offering valuable insights for stakeholders looking to make informed decisions and strategies for market growth.

Market Dynamics:

1. Key Market Drivers:

  • Advancements in Diagnostic Technologies: Technological innovations, such as PCR and NGS, are enhancing the accuracy and efficiency of molecular diagnostics.
  • Rising Incidence of Chronic Diseases: Increasing prevalence of chronic diseases, including cancer and genetic disorders, is driving demand for advanced diagnostic solutions.
  • Growing Focus on Personalized Medicine: The emphasis on personalized medicine and targeted therapies is boosting the demand for molecular diagnostic tools and technologies.

2. Key Market Challenges:

  • High Cost of Advanced Technologies: The cost of sophisticated molecular diagnostic instruments and technologies can be a barrier to widespread adoption.
  • Complexity of Regulatory Compliance: Meeting regulatory requirements for molecular diagnostic products can be challenging for market participants.
  • Need for Skilled Personnel: The complexity of molecular diagnostic techniques requires skilled personnel for operation and interpretation.

Market Trends:

  • Integration of AI and Automation: The use of artificial intelligence (AI) and automation in molecular diagnostics is improving diagnostic accuracy and efficiency.
  • Expansion of NGS Applications: The growing application of next-generation sequencing (NGS) in genomics and personalized medicine is a significant trend in the market.

Market Size Estimation

The global molecular diagnostics market is projected to reach USD 20 billion by 2030, growing at a CAGR of 8% from 2024 to 2030. This growth is driven by technological advancements, increasing disease prevalence, and a rising focus on personalized medicine.

Market Segmentation:

1. By Product:

  • Instruments: Includes diagnostic machines and analyzers for molecular testing.
  • Reagents: Covers test reagents and consumables used in molecular diagnostics.
  • Software: Involves diagnostic software and data management tools.

2. By Technology:

  • Polymerase Chain Reaction (PCR): Widely used for amplifying and analyzing DNA.
  • Next-Generation Sequencing (NGS): Advanced sequencing technology for genomics and personalized medicine.
  • In Situ Hybridization: Technique for detecting specific nucleic acid sequences in tissue samples.
  • Others: Includes additional molecular diagnostic technologies.

3. By Application:

  • Infectious Diseases: Diagnostics for infections caused by bacteria, viruses, and other pathogens.
  • Oncology: Cancer diagnostics and monitoring using molecular techniques.
  • Genetic Disorders: Diagnosis of genetic conditions and mutations.
  • Others: Includes additional applications such as autoimmune diseases and pharmacogenomics.

4. By End-User:

  • Hospitals: Utilize molecular diagnostics for patient care and disease management.
  • Diagnostic Laboratories: Specialized facilities providing molecular testing services.
  • Research Institutes: Institutions involved in molecular research and development.
  • Others: Includes academic institutions and public health organizations.

5. By Region:

  • North America: Leading in market size due to advanced healthcare infrastructure and high investment in research and technology.
  • Europe: Significant growth driven by technological advancements and regulatory support.
  • Asia Pacific: High growth potential due to increasing healthcare access and rising disease prevalence.
  • Latin America: Steady growth influenced by improving diagnostic capabilities and healthcare investments.
  • Middle East and Africa: Growth driven by expanding healthcare infrastructure and increased focus on molecular diagnostics.

Competitive Landscape

Key players in the molecular diagnostics market include:

  • Roche Diagnostics: Offers a range of molecular diagnostic instruments and reagents.
  • Thermo Fisher Scientific: Provides advanced molecular diagnostic technologies and solutions.
  • Abbott Laboratories: Known for its molecular diagnostic instruments and reagents.
  • Illumina: Specializes in next-generation sequencing technologies and solutions.
  • Qiagen: Offers molecular diagnostic products and solutions for various applications.

Market Forecast

The molecular diagnostics market is expected to grow significantly, driven by technological advancements, increasing disease prevalence, and a growing focus on personalized medicine. The expansion of NGS applications and the integration of AI and automation are expected to contribute to market growth.

Regulatory Framework

The market operates under stringent regulatory oversight from organizations such as the FDA in the United States and the EMA in Europe, ensuring the safety, efficacy, and quality of molecular diagnostic products.

Customer Landscape

The market serves a diverse customer base, including hospitals, diagnostic laboratories, research institutes, and academic institutions. Each segment has specific needs and requirements for molecular diagnostic solutions.

Regional Analysis

North America leads the market due to its advanced healthcare infrastructure, while Asia Pacific is expected to experience the highest growth rate due to increasing healthcare access and rising disease prevalence.

Table of Contents

1. Executive Summary
2. Market Introduction
2.1. Market Definition
2.2. Market Segmentation
2.3. Research Methodology
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Global Molecular Diagnostics Market, by Product
4.1. Instruments
4.2. Reagents
4.3. Software
4.4. Others
5. Global Molecular Diagnostics Market, by Technology
5.1. PCR-Based
5.2. Next-Generation Sequencing (NGS)
5.3. in Situ Hybridization
5.4. Microarrays
5.5. Others
6. Global Molecular Diagnostics Market, by Application
6.1. Oncology
6.2. Infectious Diseases
6.3. Genetic Disorders
6.4. Blood Screening
6.5. Others
7. Global Molecular Diagnostics Market, by End-User
7.1. Hospitals
7.2. Diagnostic Laboratories
7.3. Research Institutions
7.4. Others
8. Global Molecular Diagnostics Market, by Region
8.1. North America
8.1.1. United States
8.1.2. Canada
8.1.3. Mexico
8.2. Europe
8.2.1. Germany
8.2.2. United Kingdom
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Netherlands
8.2.7. Switzerland
8.2.8. Sweden
8.2.9. Rest of Europe
8.3. Asia Pacific
8.3.1. China
8.3.2. Japan
8.3.3. India
8.3.4. South Korea
8.3.5. Australia
8.3.6. Singapore
8.3.7. Malaysia
8.3.8. Thailand
8.3.9. Vietnam
8.3.10. Rest of Asia Pacific
8.4. Latin America
8.4.1. Brazil
8.4.2. Argentina
8.4.3. Rest of Latin America
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. South Africa
8.5.3. Rest of Middle East and Africa
9. Competitive Landscape
9.1. Market Share Analysis
9.2. Company Profiles
9.2.1. Roche Holding AG
9.2.2. Thermo Fisher Scientific Inc.
9.2.3. Abbott Laboratories
9.2.4. Agilent Technologies, Inc.
9.2.5. QIAGEN N.V.
9.2.6. Bio-Rad Laboratories, Inc.
9.2.7. Hologic, Inc.
9.2.8. Danaher Corporation
9.2.9. Siemens Healthineers
9.2.10. Illumina, Inc.
10. Conclusion and Future Outlook11. Appendix
List of Tables
Table 1: Global Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 2: Global Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 3: Global Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 4: Global Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 5: North America Molecular Diagnostics Market Value by Country, 2022-2030 (USD Million)
Table 6: United States Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 7: United States Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 8: United States Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 9: United States Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 10: Canada Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 11: Canada Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 12: Canada Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 13: Canada Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 14: Mexico Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 15: Mexico Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 16: Mexico Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 17: Mexico Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 18: Europe Molecular Diagnostics Market Value by Country, 2022-2030 (USD Million)
Table 19: Germany Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 20: Germany Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 21: Germany Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 22: Germany Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 23: United Kingdom Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 24: United Kingdom Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 25: United Kingdom Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 26: United Kingdom Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 27: France Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 28: France Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 29: France Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 30: France Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 31: Italy Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 32: Italy Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 33: Italy Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 34: Italy Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 35: Spain Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 36: Spain Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 37: Spain Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 38: Spain Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 39: Russia Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 40: Russia Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 41: Russia Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 42: Russia Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 43: Rest of Europe Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 44: Rest of Europe Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 45: Rest of Europe Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 46: Rest of Europe Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 47: Asia Pacific Molecular Diagnostics Market Value by Country, 2022-2030 (USD Million)
Table 48: China Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 49: China Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 50: China Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 51: China Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 52: Japan Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 53: Japan Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 54: Japan Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 55: Japan Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 56: India Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 57: India Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 58: India Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 59: India Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 60: Australia Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 61: Australia Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 62: Australia Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 63: Australia Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 64: South Korea Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 65: South Korea Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 66: South Korea Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 67: South Korea Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 68: ASEAN Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 69: ASEAN Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 70: ASEAN Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 71: ASEAN Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 72: Rest of Asia-Pacific Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 73: Rest of Asia-Pacific Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 74: Rest of Asia-Pacific Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 75: Rest of Asia-Pacific Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 76: MEA Molecular Diagnostics Market Value by Country, 2022-2030 (USD Million)
Table 77: Turkey Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 78: Turkey Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 79: Turkey Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 80: Turkey Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 81: Saudi Arabia Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 82: Saudi Arabia Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 83: Saudi Arabia Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 84: Saudi Arabia Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 85: UAE Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 86: UAE Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 87: UAE Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 88: UAE Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 89: South Africa Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 90: South Africa Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 91: South Africa Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 92: South Africa Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 93: Rest of MEA Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 94: Rest of MEA Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 95: Rest of MEA Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 96: Rest of MEA Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 97: South America Molecular Diagnostics Market Value by Country, 2022-2030 (USD Million)
Table 98: Brazil Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 99: Brazil Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 100: Brazil Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 101: Brazil Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 102: Argentina Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 103: Argentina Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 104: Argentina Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 105: Argentina Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 106: Rest of South America Molecular Diagnostics Market Value by Product, 2022-2030 (USD Million)
Table 107: Rest of South America Molecular Diagnostics Market Value by Technology, 2022-2030 (USD Million)
Table 108: Rest of South America Molecular Diagnostics Market Value by Application, 2022-2030 (USD Million)
Table 109: Rest of South America Molecular Diagnostics Market Value by End-User, 2022-2030 (USD Million)
Table 110: Company Regional Footprint
Table 111: Company Industry Footprint
List of Figures
Figure 1: Global Molecular Diagnostics Market Segments
Figure 2: Research Timelines
Figure 3: Data Triangulation Method
Figure 4: Market Research Flow
Figure 5: Data Sources
Figure 6: Executive Summary
Figure 7: Global Molecular Diagnostics Market Estimates and Forecast (USD Million), 2022-2031
Figure 8: Global Molecular Diagnostics Market Absolute Market Opportunity
Figure 9: Global Molecular Diagnostics Market Attractiveness Analysis, by Region
Figure 10: Global Molecular Diagnostics Market Attractiveness Analysis, by Product
Figure 11: Global Molecular Diagnostics Market Attractiveness Analysis, by Technology
Figure 12: Global Molecular Diagnostics Market Attractiveness Analysis, by Application
Figure 13: Global Molecular Diagnostics Market Attractiveness Analysis, by End-User
Figure 14: Global Molecular Diagnostics Market Geographical Analysis, 2024-2031
Figure 15: Global Molecular Diagnostics Market, by Product (USD Million)
Figure 16: Global Molecular Diagnostics Market, by Technology (USD Million)
Figure 17: Global Molecular Diagnostics Market, by Application (USD Million)
Figure 18: Global Molecular Diagnostics Market, by End-User (USD Million)
Figure 19: Future Market Opportunities
Figure 20: Global Molecular Diagnostics Market Outlook
Figure 21: Porter's Five Forces Analysis
Figure 22: Global Molecular Diagnostics Market, by Product
Figure 23: Global Molecular Diagnostics Market Basis Point Share (BPS) Analysis, by Product
Figure 24: Global Molecular Diagnostics Market, by Technology
Figure 25: Global Molecular Diagnostics Market Basis Point Share (BPS) Analysis, by Technology
Figure 26: Global Molecular Diagnostics Market, by Application
Figure 27: Global Molecular Diagnostics Market Basis Point Share (BPS) Analysis, by Application
Figure 28: Global Molecular Diagnostics Market, by End-User
Figure 29: Global Molecular Diagnostics Market Basis Point Share (BPS) Analysis, by End-User
Figure 30: Global Molecular Diagnostics Market, by Geography, 2022-2031 (USD Million)
Figure 31: North America Market Snapshot
Figure 32: U.S. Market Snapshot
Figure 33: Canada Market Snapshot
Figure 34: Mexico Market Snapshot
Figure 35: Europe Market Snapshot
Figure 36: Germany Market Snapshot
Figure 37: UK Market Snapshot
Figure 38: France Market Snapshot
Figure 39: Italy Market Snapshot
Figure 40: Russia Market Snapshot
Figure 41: Spain Market Snapshot
Figure 42: Rest of Europe Market Snapshot
Figure 43: Asia-Pacific Market Snapshot
Figure 44: China Market Snapshot
Figure 45: India Market Snapshot
Figure 46: Japan Market Snapshot
Figure 47: Australia Market Snapshot
Figure 48: South Korea Market Snapshot
Figure 49: ASEAN Market Snapshot
Figure 50: Rest of Asia-Pacific Market Snapshot
Figure 51: MEA Market Snapshot
Figure 52: Turkey Market Snapshot
Figure 53: UAE Market Snapshot
Figure 54: Saudi Arabia Market Snapshot
Figure 55: South Africa Market Snapshot
Figure 56: Rest of MEA Market Snapshot
Figure 57: South America Market Snapshot
Figure 58: Brazil Market Snapshot
Figure 59: Argentina Market Snapshot
Figure 60: Rest of South America Market Snapshot
Figure 61: Company Market Ranking Analysis
Figure 62: Ace Matrix
Figure 63: Roche Holding AG - Company Insights
Figure 64: Roche Holding AG - Segment Breakdown
Figure 65: Roche Holding AG - SWOT Analysis
Figure 66: Thermo Fisher Scientific Inc. - Company Insights
Figure 67: Thermo Fisher Scientific Inc. - Segment Breakdown
Figure 68: Thermo Fisher Scientific Inc. - SWOT Analysis
Figure 69: Abbott Laboratories - Company Insights
Figure 70: Abbott Laboratories - Segment Breakdown
Figure 71: Abbott Laboratories - SWOT Analysis
Figure 72: Agilent Technologies, Inc. - Company Insights
Figure 73: Agilent Technologies, Inc. - Segment Breakdown
Figure 74: Agilent Technologies, Inc. - SWOT Analysis
Figure 75: QIAGEN N.V. - Company Insights
Figure 76: QIAGEN N.V. - Segment Breakdown
Figure 77: QIAGEN N.V. - SWOT Analysis
Figure 78: Bio-Rad Laboratories, Inc. - Company Insights
Figure 79: Bio-Rad Laboratories, Inc. - Segment Breakdown
Figure 80: Bio-Rad Laboratories, Inc. - SWOT Analysis
Figure 81: Hologic, Inc. - Company Insights
Figure 82: Hologic, Inc. - Segment Breakdown
Figure 83: Hologic, Inc. - SWOT Analysis
Figure 84: Danaher Corporation - Company Insights
Figure 85: Danaher Corporation - Segment Breakdown
Figure 86: Danaher Corporation - SWOT Analysis
Figure 87: Siemens Healthineers - Company Insights
Figure 88: Siemens Healthineers - Segment Breakdown
Figure 89: Siemens Healthineers - SWOT Analysis
Figure 90: Illumina, Inc. - Company Insights
Figure 91: Illumina, Inc. - Segment Breakdown
Figure 92: Illumina, Inc. - SWOT Analysis

Companies Mentioned

  • Roche Holding AG
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • QIAGEN N.V.
  • Bio-Rad Laboratories Inc.
  • Hologic Inc.
  • Danaher Corporation
  • Siemens Healthineers
  • Illumina Inc.

Related Topics

Related Reports

Global Molecular Diagnostics Market by Technology (Chips and Microarrays, In Situ Hybridization, Mass Spectrometry (MS)), Product (Instruments, Reagents), Application, End User - Forecast 2024-2030 - Product Image

Global Molecular Diagnostics Market by Technology (Chips and Microarrays, In Situ Hybridization, Mass Spectrometry (MS)), Product (Instruments, Reagents), Application, End User - Forecast 2024-2030

  • Report
  • 187 Pages
  • Global
From
Global Point-of-Care Molecular Diagnostics Market Size, Share & Trends Analysis Report by Application (Infectious Diseases, Oncology, Prenatal Testing), Technology, Test Location, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Point-of-Care Molecular Diagnostics Market Size, Share & Trends Analysis Report by Application (Infectious Diseases, Oncology, Prenatal Testing), Technology, Test Location, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • Global
From
Global Point of Care Molecular Diagnostics Market by Product (Analyzers, Kits & Assays, Software & Services), Technology (Isothermal Nucleic Acid Amplification Technology, Real-Time Polymerase Chain Reaction), Application, End-User - Forecast 2024-2030 - Product Image

Global Point of Care Molecular Diagnostics Market by Product (Analyzers, Kits & Assays, Software & Services), Technology (Isothermal Nucleic Acid Amplification Technology, Real-Time Polymerase Chain Reaction), Application, End-User - Forecast 2024-2030

  • Report
  • 184 Pages
  • Global
From
Molecular Diagnostics Market Size, Share & Trends by Product & Services (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH, INAAT), Application (Infectious (Hepatitis, HIV, HAI, TB, HPV), Oncology) - Global Forecast to 2029 - Product Image

Molecular Diagnostics Market Size, Share & Trends by Product & Services (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH, INAAT), Application (Infectious (Hepatitis, HIV, HAI, TB, HPV), Oncology) - Global Forecast to 2029

  • Report
  • 447 Pages
  • Global
From
Global Oncology Based Molecular Diagnostics Market Size, Share & Trends Analysis Report by Type (Breast Cancer, Lung Cancer), Product (Instruments, Reagents), Technology (PCR, Sequencing), Region, and Segment Forecasts, 2023-2030 - Product Image

Global Oncology Based Molecular Diagnostics Market Size, Share & Trends Analysis Report by Type (Breast Cancer, Lung Cancer), Product (Instruments, Reagents), Technology (PCR, Sequencing), Region, and Segment Forecasts, 2023-2030

  • Report
  • 139 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.